CYP2C19 and major depressive disorder: Data on the impact of CYP2C19 genotype on antidepressant treatment effects in bipolar depression is scarce [16], but one study suggested that the CYP2C19 poor metabolism phenotype is more prevalent in treatment resistant bipolar disorder compared with treatment resistant major depressive disorder [17].